Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease

Heart

Volumn 97, Issue 16, 2011, Pages 1338-1342

  Wöhrle, Jochen ^a   Birkemeyer, Ralf ^b   Markovic, Sinisa ^a   Nguyen, The Vinh ^a   Sinha, Anil ^c   Miljak, Tomislav ^b   Spiess, Jochen ^a   Rottbauer, Wolfgang ^a   Rittger, Harald ^c  

^a UNIVERSITY OF ULM   (Germany)

^b SCHWARZWALD BAAR KLINIKUM   (Germany)

^c KLINIKUM COBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BALLOON CATHETER; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; ENDOTHELIAL PROGENITOR CELL CAPTURING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEOINTIMA; PACLITAXEL COATED BALLOON ANGIOPLASTY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SINGLE BLIND PROCEDURE; STENT THROMBOSIS;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; ANTIBODIES, MONOCLONAL; ANTIGENS, CD34; COATED MATERIALS, BIOCOMPATIBLE; COMBINED MODALITY THERAPY; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; SINGLE-BLIND METHOD; STEM CELLS; TREATMENT OUTCOME; TUBULIN MODULATORS;

EID: 79960698071     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2011.226563     Document Type: Article

References (22)

1. Wenaweser P, Daemen J, Zwahlen M, et al. Incidence and correlates of drugeluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol 2008;52:1134-40.
2. Finn AV, Nakazawa G, Joner M, et al. Vascular responses to drug eluting stents. Importance of delayed healing. Arterioscler Thromb Vasc Biol 2007;27:1500-10.
3. Hwang CW, Wu D, Edelman ER. Physiological transport forces govern drug distribution for stent-based delivery. Circulation 2001;104:600-5. (Pubitemid 32738132)
4. Scheller B, Speck U, Böhm M. Prevention of restenosis: is angioplasty the answer? Heart 2007;93:539-41.
5. Aoki J, Serruys PW, van Beusekom H, et al. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol 2005;45:1574-9. (Pubitemid 40704488)
6. Duckers HJ, Silber S, de Winter R, et al. Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent. EuroIntervention 2007;3:67-75.
7. Beijk MA, Klomp M, Verouden NJ, et al. Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study. Eur Heart J 2010;31:1055-64.
8. Wöhrle J, Nusser T, Langenwalder S, et al. Carbon coated stents in patients with acute coronary syndromes. Clin Cardiol 2009;32:E1-6.
9. Rinker A, Nusser T, Grossmann G, et al. Angiographic results of a Tacrolimus-eluting stent in acute coronary syndrome lesions. Clin Res Cardiol 2009;98:89-93.
10. Wöhrle J, Nusser T, Hofmann S, et al. Angiographic results of the cobalt-chromium Vision and Mini-Vision stents. Can J Cardiol 2009;25:581-4.
11. Herdeg C, Göhring-Frischholz K, Haase KK, et al. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation. Circ Cardiovasc Interv 2009;2:294-301.
12. Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis. Classification and implications for long-term outcome. Circulation 1999;100:1872-8.
13. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-51. (Pubitemid 46685903)
14. Rowland S, Cottone R, Davis HR, et al. Genous bio-engineered R-stent: development, and HEALING clinical evaluations. In: Serruys PW, Gershlick A, eds. Handbook of Drug-Eluting Stents. Andover: Taylor and Francis, 2005.
15. Shirota T, Yasui H, Shimokawa H, et al. Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials 2003;24:2295-302. (Pubitemid 36434048)
16. Miglionico M, Patti G, D'Ambrosio A, et al. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients. Catheter Cardiovasc Interv 2008;71:600-4. (Pubitemid 351550395)
17. Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 2005;294:1215-23. (Pubitemid 41352109)
18. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31. (Pubitemid 38067635)
19. Scheller B, Hehrlein C, Bocksch W, et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006;355:2113-24. (Pubitemid 44749319)
20. Unverdorben M, Kleber FX, Heuer H, et al. Treatment of small coronary arteries with paclitaxel-coated balloon catheter. Clin Res Cardiol 2010;99:165-74.
21. Cortese B, Micheli A, Picchi A, et al. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart 2010;96:1291-6.
22. Hamm CW, Cremers B, Moellmann H, et al. PEPCAD III: a randomized trial comparing paclitaxel-coated balloon/stent system with a sirolimus eluting stent (abstract). Circulation 2009;120:2157.